FRED ALGER MANAGEMENT, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRED ALGER MANAGEMENT, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$5,000
-85.7%
47
-87.1%
0.00%
Q3 2020$35,000
-100.0%
364
-99.9%
0.00%
-100.0%
Q2 2020$89,185,000
-32.8%
726,735
-52.1%
0.29%
+0.7%
Q1 2020$132,808,000
+65.7%
1,516,594
+97.8%
0.29%
-1.0%
Q4 2019$80,163,000
+9.7%
766,671
+20.7%
0.30%
+2.8%
Q3 2019$73,045,000
-15.3%
635,004
+26.9%
0.29%
-13.3%
Q2 2019$86,284,000
+23.8%
500,519
+21.1%
0.33%
+19.1%
Q1 2019$69,679,000
+2.7%
413,356
-40.7%
0.28%
-10.9%
Q4 2018$67,841,000
+5.7%
696,594
+87.5%
0.31%
+29.5%
Q3 2018$64,174,000
+43.0%
371,509
+15.5%
0.24%
+28.2%
Q2 2018$44,888,000
+321.9%
321,688
+240.7%
0.19%
+283.7%
Q1 2018$10,639,000
+86.3%
94,424
+118.3%
0.05%
+88.5%
Q4 2017$5,710,000
+149.8%
43,256
+92.1%
0.03%
+136.4%
Q3 2017$2,286,000
+356.3%
22,521
+350.4%
0.01%
+450.0%
Q2 2017$501,000
-17.2%
5,0000.0%0.00%
-33.3%
Q1 2017$605,000
+20.3%
5,000
+11.1%
0.00%0.0%
Q4 2016$503,000
+8.2%
4,500
+28.6%
0.00%
+50.0%
Q3 2016$465,000
+125.7%
3,500
+55.6%
0.00%
+100.0%
Q2 2016$206,000
-74.2%
2,250
-80.4%
0.00%
-75.0%
Q4 2015$799,000
+21.4%
11,500
+59.7%
0.00%0.0%
Q3 2015$658,0007,2000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders